264 related articles for article (PubMed ID: 21962913)
41. Aberrant regulation of NMDA receptors by dopamine D4 signaling in rats after phencyclidine exposure.
Wang X; Gu Z; Zhong P; Chen G; Feng J; Yan Z
Mol Cell Neurosci; 2006 Jan; 31(1):15-25. PubMed ID: 16198123
[TBL] [Abstract][Full Text] [Related]
42. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
43. Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing.
Klamer D; Svensson L; Fejgin K; Pålsson E
Eur Neuropsychopharmacol; 2011 Mar; 21(3):248-53. PubMed ID: 21111580
[TBL] [Abstract][Full Text] [Related]
44. Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus.
Wang XD; Su YA; Guo CM; Yang Y; Si TM
Int J Neuropsychopharmacol; 2008 Jun; 11(4):553-61. PubMed ID: 18184445
[TBL] [Abstract][Full Text] [Related]
45. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
46. Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.
Kotzadimitriou D; Nissen W; Paizs M; Newton K; Harrison PJ; Paulsen O; Lamsa K
eNeuro; 2018; 5(2):. PubMed ID: 29740596
[TBL] [Abstract][Full Text] [Related]
47. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG
Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909
[TBL] [Abstract][Full Text] [Related]
48. Neuregulin-1 protects against neurotoxicities induced by Swedish amyloid precursor protein via the ErbB4 receptor.
Woo RS; Lee JH; Kim HS; Baek CH; Song DY; Suh YH; Baik TK
Neuroscience; 2012 Jan; 202():413-23. PubMed ID: 22186019
[TBL] [Abstract][Full Text] [Related]
49. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
50. Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats.
Rasmussen BA; O'Neil J; Manaye KF; Perry DC; Tizabi Y
Psychopharmacology (Berl); 2007 Jan; 190(1):43-9. PubMed ID: 17047931
[TBL] [Abstract][Full Text] [Related]
51. Increased Seizure Susceptibility for Rats Subject to Early Life Hypoxia Might Be Associated with Brain Dysfunction of NRG1-ErbB4 Signaling in Parvalbumin Interneurons.
Liang D; Fan F; Ding W; Fang Y; Hu L; Lei B; Zhang M
Mol Neurobiol; 2020 Dec; 57(12):5276-5285. PubMed ID: 32870492
[TBL] [Abstract][Full Text] [Related]
52. Necl-2/CADM1 interacts with ErbB4 and regulates its activity in GABAergic neurons.
Yamada A; Inoue E; Deguchi-Tawarada M; Matsui C; Togawa A; Nakatani T; Ono Y; Takai Y
Mol Cell Neurosci; 2013 Sep; 56():234-43. PubMed ID: 23769722
[TBL] [Abstract][Full Text] [Related]
53. Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse.
Okada M; Corfas G
Hippocampus; 2004; 14(3):337-44. PubMed ID: 15132433
[TBL] [Abstract][Full Text] [Related]
54. Expression of ErbB3, ErbB4, and neuregulin-1 mRNA during tooth development.
Fried K; Risling M; Tidcombe H; Gassmann M; Lillesaar C
Dev Dyn; 2002 Jul; 224(3):356-60. PubMed ID: 12112465
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
56. Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation.
Pregno G; Zamburlin P; Gambarotta G; Farcito S; Licheri V; Fregnan F; Perroteau I; Lovisolo D; Bovolin P
BMC Neurosci; 2011 Oct; 12():103. PubMed ID: 21991932
[TBL] [Abstract][Full Text] [Related]
57. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
Shi WX; Zhang XX
J Pharmacol Exp Ther; 2003 May; 305(2):680-7. PubMed ID: 12606677
[TBL] [Abstract][Full Text] [Related]
58. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
[TBL] [Abstract][Full Text] [Related]
59. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
60. Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.
Feng Y; Wang XD; Guo CM; Yang Y; Li JT; Su YA; Si TM
J Biomed Biotechnol; 2010; 2010():859516. PubMed ID: 20467458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
